Chelsea's Ukrainian winger edges toward a first taste of competitive action since a drugs suspension shelved his career.
Mykhailo Mudryk has been named in Chelsea's travelling squad for Wednesday's friendly against Juventus in Hong Kong. The inclusion ends, or at least pauses, nearly 20 months of enforced absence from match action.
The Ukrainian winger has not featured since news of a failed doping test surfaced in December 2023. He was provisionally suspended days later, cutting short a campaign that had begun to show faint signs of promise under then-head coach Mauricio Pochettino.
Since that provisional ban, Chelsea have changed managers twice and recalibrated their attacking structure more times than anyone at Stamford Bridge cares to count. The club kept Mudryk on the payroll, did not push to terminate his contract, and quietly maintained his training regimen.
This is a friendly, staged in a commercial market. Mudryk's presence on the squad sheet signals availability rather than a guarantee of minutes.
Chelsea face Juventus at the Hong Kong Stadium as part of their preseason tour. If he appears, even briefly, it would be the winger's first match involvement since the suspension began.
Mudryk arrived from Shakhtar Donetsk for a fee reported to be in the region of £62 million, rising with add-ons to a potential £88 million, in the January 2023 window. Chelsea beat Arsenal to his signature and Todd Boehly's regime celebrated the deal as a marquee signing.
His Chelsea record before the suspension was modest. Across roughly 41 Premier League appearances, he registered two goals and a handful of assists. The transfer fee became a running source of frustration among supporters.
Current head coach Enzo Maresca inherits a crowded attacking department. Noni Madueke, Cole Palmer, Pedro Neto, and Nicolas Jackson have all featured prominently in preseason planning.
Mudryk, even with his ban lifted, sits behind that group in the current hierarchy. A Hong Kong appearance would be less about staking a claim to a starting role and more about demonstrating physical readiness after more than a year and a half without competitive football.
Mudryk maintained he did not knowingly ingest a banned substance, a position Chelsea publicly backed. The timeline of the case has remained opaque, with the club working behind closed doors to manage both the regulatory process and the player's training load.
According to reports from Chelsea's tour camp, the mood around Mudryk's potential return has been positive. Players and staff have treated his availability as a quiet boost rather than a dramatic event.
We have been waiting for him. The most important thing is he is back with us and available. We will see what happens.
Those around the squad describe Mudryk as visibly emotional at being back in a matchday frame, even for a friendly. After 20 months of training in isolation or with the club's sports science team, the return to squad selection is its own milestone.
Twenty months without competitive football strips a player of two things that are difficult to rebuild: match sharpness and rhythm under pressure.
Mudryk is 23 years old, still within the window where a stalled career can recover trajectory. The margins are thinner now. Every preseason opportunity has to be maximized.
Maresca's system favors wide players who can pin back fullbacks and isolate in one-on-one situations. Mudryk's raw pace has always been his most bankable attribute. If he can rediscover that burst in Hong Kong, a tactical reentry becomes conceivable by September.
Mudryk's inclusion in the Juventus friendly squad does not answer the questions about his suspension, his price tag, or his long-term suitability to Maresca's project. It extends a timeline that many assumed was closed. Chelsea have not written off a £62 million-plus investment. Maresca now has another attacking option, however raw, to evaluate across the remaining preseason fixtures. And Mudryk has a chance to prove that the most expensive footnote of the Boehly era might still become a footballer.
This is an original SportPulse article written by our editorial team. All content is independently researched, written, and reviewed by our writers and editors before publication. We do not publish copied, aggregated, or syndicated content.
SportPulse is committed to original sports journalism. Read our editorial policy or contact us with any questions.